|
Diabetes drug looks safe for heart failure patients
The diabetes drug metformin previously carried a "black box" warning from the U.S. Food and Drug Administration advising against its use in treating diabetes in heart failure patients. But a 14-year study of 401 patients with type 2 diabetes and advanced systolic heart failure suggests that metformin is safe and may be associated with better heart failure survival, say U.S. researchers...
Diabetes meds may be falling through 'doughnut hole'
Medicare's so-called "doughnut hole" could be forcing many American seniors to skip their diabetes medications, a new study suggests…
Fat hormone controls gene linked to diabetes
A fat hormone known as leptin controls a gene in the liver that's linked to the dampening of diabetes in animals. The finding suggests that the hormone could potentially have the same effect in people, says a study published in Cell Metabolism…
Markers predict kids' risk of diabetes as adults
Body measurements and laboratory tests may predict the likelihood that a child will develop type 2 diabetes later in life, suggest long-term studies of black and white children…
New guidelines urge A1C test for diabetes diagnosis
In its latest set of clinical guidelines, the American Diabetes Association is promoting a more prominent role for the hemoglobin A1C blood test in the diagnosis of type 2 diabetes and prediabetes.
Long used in the management of diabetes, the A1C blood test measures average blood sugar levels for the previous two to three months. The new guidelines call for the diagnosis of type 2 diabetes at A1C levels above 6.5 percent, and prediabetes if the A1C levels are between 5.7 and 6.4 percent. The new guidelines are in Diabetes Care…
Diabetics less prone now to end-stage kidney disease
The incidence of end-stage kidney disease, one of the most serious complications of diabetes, rose steadily in people with diabetes for decades. But, in 1996, the rate of diabetes-related end-stage kidney disease finally began to decline. Since then, the incidence has dropped about 3.9 percent a year, a new government study finds…
Diabetes drugs go head-to-head in study
A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treatment metformin. Sulfonylureas performed less well than metformin in a study of oral anti-diabetes drugs, but doctors said the findings aren't necessarily a reason to discontinue taking them…
|